Document is current
Any future updates will be listed below
-
Authors
Fuery, Michael A.
Clark, Katherine A.
Sikand, Nikhil V.
Tabtabai, Sara R.
Sen, Sounok
Wilson, F. Perry
Desai, Nihar R.
Ahmad, Tariq
Samsky, Marc D.
- License Information
-
More Information
Article History
Accepted: 3 March 2025
First Online: 19 March 2025
Declarations
:
: Drs. Fuery, Clark, Tabtabai, Sen, and Samsky have no conflicts of interest or financial ties to disclose. Dr. Sikand reports being a consultant for Bristol Myers Squibb and Bayer. Dr. Wilson reports grant funding from NIDDK, AHRQ, DOD, Amgen, Boeringher-Ingelheim, and Whoop and consulting for Aura.Care and WndrHLTH. Dr Ahmad has received consulting fees from Sanofi, Amgen, and Cytokinetics; and research funding from AstraZeneca, Boehringer Ingelheim, Cytokinetics, and Relypsa. Dr. Desai works under contract with the Centers for Medicare and Medicaid Services to develop and maintain performance measures used for public reporting and pay-for-performance programs. He also reports research grants and consulting for Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CSL Behring, Cytokinetics, Merck, Novartis, SCPharmaceuticals, and Vifor.
: The authors declare no competing interests.
